Specificity of plasma membrane targeting by the Rous sarcoma virus Gag protein

Journal of Virology

Volumn 77, Issue 1, 2003, Pages 470-480

  Scheifele, Lisa Z ^a   Rhoads, Jonathan D ^a   Parent, Leslie J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN TARGETING; RETROVIRUS; ROUS SARCOMA ONCOVIRUS;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; ANIMALS; AVIAN SARCOMA VIRUSES; CELL LINE; CELL MEMBRANE; GENE PRODUCTS, GAG; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN TRANSPORT;

EID: 0037216414     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.1.470-480.2003     Document Type: Article

References (59)

1. Apolloni, A., A. Prior, M. Lindsay, R. G. Parton, and J. F. Hancock. 2000. H-Ras but not K-Ras traffics to the plasma membrane through the exocytic palhway. Mol. Cell. Biol. 20:2475-2487.
2. Bryant, M., and L. Ratner. 1990. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 87:523-527.
3. Callahan, E. M., and J. W. Wills. 2000. Repositioning basic residues in the M domain of the Rous sarcoma virus Gag protein. J. Virol. 74: 11222-11229.
4. Hck-positlve lysosomes. J. Biol. Chem. 275:36223-36229.
5. Choy, E., V. K. Chiu, J. Silletti, M. Feoktistov, T. Morimoto, D. Michaelson, I. E. Iranov, and M. R. Philips. 1999. Endomembrane trafficking of Ras: The CAAX motif targets proteins to the ER and Golgi. Cell 98:69-80.
6. Craven, R. C., A, E. Leure-duPree, R. A. Weldon, Jr., and J. W. Wills. 1995. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J. Virol 69:4213-4227.
7. Craven, R. C., and L. J. Parent. 1996. Dynamic interactions of the Gag polyprotein. Curr. Top. Microbiol. Immunol. 214:65-94.
8. Eastman, S. W., and M. L. Linial. 2001. Identification of a conserved residue of loamy virus Gag required for intracellular capsid assembly. J. Virol. 75:6857-6864.
9. Ehrlich, L. S., S. Funs, S. Scarlata, G. Zybarth, and C. Carter. 1996. Partitioning of HIV-1 Gag and Gag-related proteins to membranes. Biochemistry 35:3933-3943.
10. Facke, M., A. Janetzko, R. L. Shoeman, and H.-G. Krausslich. 1993. A large deletion in the Matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J. Virol. 67:4972-4980.
11. z to the plasma membrane. J. Biol. Chem. 274:18793-18800.
12. Fuiwara, T., K. Oda, S. Yokota, A. Takatsuki, and Y. Ikehara. 1988. Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J. Biol. Chem. 263:18545-18552.
13. Gallina, A., G. Mantoan, G. Rindi, and G. Milanesi. 1994. Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the budding site of HIV-1 Gag protein. Biochem. Biophys. Res. Comm. 204: 1031-1038.
14. Garhitt, R. A., J. A. Alhert, M. D. Kessler, and L. J. Parent. 2001. Trans-acting inhibition of genomic RNA dimerization by Rous sarcoma virus matrix mutants. J. Virol. 75:260-268.
15. Gottlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-5785.
16. Hanson, M., L. Jelinek, S. Whiting, and E. Barklis. 1990. Transport and assembly of gag proteins into Moloney murine leukemia virus. J. Virol. 64:5306-5316.
17. Hatanaka, H., O. Iourin, Z. Rao, E. Fry, A. Kingsman, and D. I. Stuart. 2002. Structure of equine infectious anemia virus matrix protein. J. Virol. 76:1876-1883.
18. gag and p17MA. J. Virol. 73:1902-1908.
19. Hermida-Matsumoto, L., and M. D. Resh. 2000. Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J. Virol. 74:8670-8679.
20. Krishna, N. K., S. Campbell, V. M. Vogt, and J. W. Wills. 1998. Genetic determinants of Rous sarcoma virus particle size. J. Virol. 72:564-577.
21. Krishna, N. K., R. A. Weldon, Jr., and J. W. Wills. 1996. Transport and processing of the Rous sarcoma virus Gag protein in the endoplasmic reticulum. J. Virol. 70:1570-1579.
22. Kunkel, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-specific mulagenesis without phenotypic selection. Methods Enzymol. 154:367-382.
23. Lindwasser, O. W., and M. D. Resh. 2001. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J. Virol. 75:7913-7924.
24. McCabe, J. B., and L. G. Berthiaume. 1999. Functional roles for fatty acylated amino-teminal domains in subcellular localization. Mol. Biol. Cell 10:3771-3786.
25. McDonnell, J. M., D. Fushman, S. M. Cahill, W. Zhou, A. Wolven, C. B. Wilson, T. D. Nelle, M. D. Resh, J. Wills, and D. Cowburn. 1998. Solution structure and dynamics of the bioactive retroviral M domain from Ruus sarcoma virus. J. Mol. Biol. 279:921-928.
26. z requires two signals. Mol. Biol. Cell 9:1-14.
27. Moscovici, C., M. G. Moscovicl, J. Jimenez, M. M. C. Lai, M. J. Hayman, and P. K. Vogt. 1977. Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell 11:95-103.
28. Murray, D., N. Ben-Tal, B. Honig, and S, McLaughlin. 1997. Electrostatic interaction of myristoylated proteins with membranes: Simple physics, complicated biology. Structure 5:985-989.
29. Nelle, T. D., and J. W. Wills. 1996. A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity. J. Virol. 70:2269-2276.
30. Nguyen, D. H., and J. E. K. Hildreth. 2000. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74:3264-3272.
31. Oho, A., and E. O. Freed. 2001. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. USA 98:13925-13930.
32. Oho, A., J. M. Orenstein, and E. O. Freed. 2000. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. J. Virol. 74:2855-2866.
33. Paillart, J.-C., and H. G. Gottlinger. 1999. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of Gag membrane targeting. J. Virol. 73:2604-2612.
34. Parent, L. J., T. M. Cairns, J. A. Albert, C. B. Wilson, J. W. Wills, and R. C. Craven. 2000. RNA dimerization defect in a Rous sarcoma virus matrix mutant. J. Virol. 74:164-172.
35. Parent, L. J., C. B. Wilson, M. D. Resh, and J. W. Wills. 1996. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein. J. Virol. 70:1016-1026.
36. Patnaik, A., V. Chau, and J. W. Wills. 2000. Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. USA 97:13069-13074.
37. Provitera, P., F. Bouamr, D. Murray, C. Carter, and S. Scarlata. 2000. Binding of equine infectious anemia virus matrix protein to membrane bilayers involves multiple interactions. J. Mol. Biol. 296:887-898.
38. Resh, M. D. 1994. Myristoylation and palmitoylation of Src family members: The fats of the matter. Cell 76:411-413.
39. Resh, M. D. 1999. Fatty acylation of proteins: New insights into membrane targeting of mylistoylated and palmitoylated proteins. Biochim. Biophys. Acta 1451:1-16.
40. Rhee, S. R., and E. Hunter. 1990. A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell 63:77-86.
41. Robbins, S. M., N. A. Quintrell, and J. M. Bishop. 1995. Myristoylation and differential palmitoylation of the HCK protein-tyrosine kinases govern their attachment to membranes and their association with caveolac. Mol. Cell. Biol. 15:3507-3515.
42. Gag. J. Virol. 72:2723-2732.
43. Scarlata, S., L. S. Ehrlich, and C. A. Carter. 1998. Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions. J. Mol. Biol. 277:161-169.
44. Scheifele, L. Z., R. A. Garbitt, J. D. Rhoads, and L. J. Parent. 2002. Nuclear entry and CRM-1 dependent nuclear export of the Rous sarcoma virus Gag polyprotein. Proc. Natl. Acad. Sci. USA 99:3944-3949.
45. Gag is excluded from virus assembly and maturation events. J. Virol. 63:2370-2373.
46. Soneoka, Y., S. M. Kingsman, and A. J. Kingsman. 1997. Mutagenesis analysis of the analysi, ofthe murine leukemia virus matrix protein: Identification of regions important for membrane localization and intracellular transport. J. Virol. 71:5549-5559.
47. Spearman, P., R. Horton, L. Ratner, and I. Kuli-Zade. 1997. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J. Virol. 71:6582-6592.
48. Spearman, P., J. J. Wang, N. Vender Heyden, and L. Ratner. 1994. Identfication of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68:3232-3242.
49. Swanstrom, R., and J. W. Wills. 1997. Synthesis, assembly, and processing of retroviral proteins., p. 263-334. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
50. van't Hof, W., and M. D. Resh. 2000. Targeting proteins to the plasma membrane and membrane microdomains by N-terminal myristoylation and palmitoylation. Methods Enzymol. 327:317-330.
51. Verderame, M. F., T. D. Nelle, and J. W. Wills. 1996. The membrane-binding domain of the Rous sarcoma virus Gag protein. J. Virol. 70:2664-2668.
52. Weldon, R. A., Jr., C. R. Erdie, M. G. Oliver, and J. W. Wills. 1990. Incorporation of chimeric Gag protein into retroviral particles. J. Virol. 64:4169-4179.
53. Welker, R., A. Janetzko, and H.-G. Krausslich. 1997. Plasma membrane targeting of chimeric intracisternal A-type particle proteins leads to particle release and specific activation of the viral proteinase. J. Virol. 71:5209-5217.
54. Wilcox, C., J.-S. Hu, and E. N. Olson. 1987. Acylation of proteins with myristic acid occurs cotranslationally. Science 238:1275-1278.
55. src. J. Virol. 65:3804-3812.
56. Wolven, A., H. Okamura, Y. Rusenblatt, and M. D. Resh. 1997. Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association. Mol. Biol. Cell 8:1159-1173.
57. Yuan, X., X. Yu, T.-H. Lee, and M. Essex. 1993. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix block intracellular transport of the Gag precursor. J. Virol. 67:6387-6394.
58. Zhou, W., L. J. Parent, J. W. Wills, and M. D. Resh. 1994. Identification of a membrane-binding domain within the amino-teminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:2556-2569.
59. Zhou, W., and M. D. Resh. 1996. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70:8540-8548.